PFE : Summary for Pfizer, Inc. - Yahoo Finance

U.S. Markets open in 2 hrs.

Pfizer Inc. (PFE)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
34.26+0.20 (+0.59%)
At close: 4:00PM EST

34.51 0.25 (0.73%)
Pre-Market: 5:59AM EST

People also watch
MRKJNJJPMGEINTC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close34.06
Open34.17
Bid0.00 x
Ask0.00 x
Day's Range33.99 - 34.35
52 Week Range28.74 - 37.39
Volume24,711,961
Avg. Volume25,908,359
Market Cap207.9B
Beta1.02
PE Ratio (TTM)29.21
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.28 (3.74%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals15 minutes ago

    Biogen alums team up to launch Waltham biotech, with backing from Henri Termeer

    A new biotech has launched in Waltham with a management team made up of former Biogen executives and $38 million in financing from Pfizer, former Genzyme CEO Henri Termeer and other prominent investors. Arrakis Therapeutics said it will focus on developing potential treatments for neurology, cancer and rare genetic disorders that target RNA, the all-important molecules that translate the instructions in DNA into proteins in the body. The $38 million Series A financing was led by California venture capital firm Canaan Partners.

  • TheStreet.com2 days ago

    Details Still Missing on Republicans' 'Once in a Generation' Tax Plan

    The GOP has lit a match on tax reform, but nobody seems to know the length or texture of the fuse.

  • Reuters2 days ago

    Pfizer subpoenaed in U.S. over patient assistance plans

    Pfizer Inc said it received subpoenas from the U.S. Attorney's Office for the District of Massachusetts related to its support for organizations that provide financial help to Medicare patients. "Pfizer is among a number of companies that have received subpoenas regarding this matter," the New York-based company said in an emailed statement on Friday. Drugmakers including Valeant Pharmaceuticals International Inc and Regeneron Pharmaceuticals Inc have disclosed involvement in similar government investigations.